PIM1 and prostate neoplasm: Clinical studies demonstrate a positive correlation between PIM1 expression and tumor metastasis in breast (Gapter et al., 2006), lung (Cao et al., 2019), pancreatic (Xu et al., 2016), and prostate tumors (Santio et al., 2015).